Alfred E. Tiefenbacher (GmbH & Co. KG)
Quick facts
Phase 3 pipeline
- Dorzolamide 2 % eye drops solution · Ophthalmology
Dorzolamide inhibits carbonic anhydrase II in the eye to reduce aqueous humor production and lower intraocular pressure.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: